Suggestions

Du même auteur

TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients

Archive ouverte | Vicier, Cecile | CCSD

International audience. Background: Hormone-resistant HER2-negative or triple-negative advanced breast cancers (ABC) are routinely treated with paclitaxel chemotherapy. LY2780301 is a dual inhibitor of p70 ribosomal...

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial. L’année 2021 dans tous ses états : une synthèse digérée

Archive ouverte | Sabatier, Renaud | CCSD

International audience. 5548 Background: Ovarian cancer is the leading cause of death by gynecological cancer. Complete surgery remains one of the main prognostic factors. Laparoscopic exploration is mandatory to as...

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Archive ouverte | Bertucci, François | CCSD

International audience. Abstract Background The benefit of precision medicine based on relatively limited gene sets and often-archived samples remains unproven. PERMED-01 (NCT02342158) was a prospective monocentric ...

Chargement des enrichissements...